Acute exposure to resveratrol inhibits AMPK activity in human skeletal muscle cells
- First Online:
- Cite this article as:
- Skrobuk, P., von Kraemer, S., Semenova, M.M. et al. Diabetologia (2012) 55: 3051. doi:10.1007/s00125-012-2691-1
- 1k Views
Recent studies have suggested resveratrol (RSV) as a new natural therapeutic agent to treat type 2 diabetes and lipid-induced insulin resistance. Here, we investigated whether RSV could reverse palmitate-induced insulin resistance in human primary muscle cells.
Myotubes obtained from six healthy men (54 ± 3 years (mean ± SE), BMI 25.0 ± 1.7 kg/m2, fasting plasma glucose concentration (fP-glucose) 5.47 ± 0.09 mmol/l) were treated for 4 h with 100 μmol/l RSV and/or 0.2 mmol/l palmitate, and stimulated with or without 100 nmol/l insulin. Assays of glucose uptake, glycogen synthesis, palmitate oxidation, intracellular signalling and AMP-activated protein kinase (AMPK) activity were performed.
RSV did not reverse palmitate-induced impairment of glucose metabolism. Surprisingly, RSV decreased glucose uptake and glycogen synthesis in human skeletal muscle cells. Palmitate oxidation and phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase β (ACCβ) were inhibited by RSV, and RSV completely blocked the activity of AMPK isoform complexes α1/β2/γ1 and α2/β2/γ1 in in-vitro kinase activity assays. Endoplasmic reticulum (ER) stress was increased in response to RSV, as indicated by increased phosphorylation of eukaryotic initiation factor 2α (eIF2α) and increased expression of CCAAT/enhancer binding protein homologous protein (CHOP).
Acute exposure to RSV inhibits AMPK activity, fatty-acid oxidation and glucose metabolism in human myotubes.
KeywordsAICARAMPKER stressInsulin resistancePrimary human myotubesResveratrol
V-akt murine thymoma viral oncogene (protein kinase B)
AMP-activated protein kinase
Binding immunoglobulin protein
CCAAT/enhancer binding protein homologous protein
Eukaryotic initiation factor 2α
Fasting plasma glucose concentration
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
Peroxisome proliferator-activated receptor γ co-activator 1
Protein kinase C
Reactive oxygen species
Unfolded protein response
Type 2 diabetes and obesity are characterised by defects in insulin signalling, glucose transport, glycogen synthesis and lipid metabolism. Elevated non-esterified fatty acids (NEFA) are regarded as one of the major causes of insulin resistance [1–3]. Exposure to NEFAs impairs insulin signalling and affects glycogen synthesis in cultured cells and rodent muscle tissue [4–7] and acute exposure of isolated muscle strips to palmitate causes insulin resistance in human skeletal muscle from obese people . Elevated NEFA levels are postulated to lead to the accumulation of active intramuscular lipid metabolites, such as diacylglycerol (DAG), long-chain Acyl-CoAs:s and ceramides, which interfere with insulin signalling via activation of serine/threonine kinases such as protein kinase C (PKC) and c-Jun N-terminal kinase (JNK) [9–11]. Therefore, interventions that impact intracellular levels of these active lipid metabolites have been suggested to improve insulin sensitivity.
Resveratrol (RSV), a natural polyphenol found in grapes and peanuts, has been proposed as a potential therapeutic agent to treat type 2 diabetes and lipid-induced insulin resistance. In obese men, treatment with RSV for 30 days is associated with reduced sleeping and resting metabolic rates and improved insulin action . However, the mechanisms of RSV action on metabolism are not fully understood. RSV reduces weight and concentration of intramuscular lipid metabolites and reactive oxygen species (ROS) in a mouse model , and it induces mitochondrial biogenesis via activation of the sirtuin 1 (SIRT1)– peroxisome proliferator-activated receptor γ co-activator 1-α (PGC-1α) pathway . Deacetylation (and activation) of PGC-1α by SIRT1 requires AMP-activated protein kinase (AMPK) activation, which is directly regulated by RSV [13, 15]. AMPK improves glucose metabolism in an insulin-independent fashion  and is a critical regulator of lipid metabolism . Given that RSV activates AMPK in animal and cell models , we tested the hypothesis that RSV could protect primary human muscle cells from palmitate-induced insulin resistance.
The sources of antibodies and reagents are described in the electronic supplementary materials (ESM) Methods.
Experimental protocols were approved by the Ethical Committee of Department of Medicine, Helsinki University Central Hospital and written informed consent was obtained from all participants. The principles of the Declaration of Helsinki were followed. Six healthy nonsmoking men (54 ± 3 years, BMI 25.0 ± 1.7 kg/m2) were studied. All had normal glucose tolerance according to WHO criteria (fasting plasma glucose concentration [fP-glucose] 5.47 ± 0.09 mmol/l, 2 h P-glucose 5.33 ± 0.54 mmol/l).
Primary human muscle cells
A small (∼100 mg) muscle biopsy from the vastus lateralis was taken under local anaesthesia (15 ml of lidocaine hydrochloride 10 mg/ml) [18, 19]. Satellite cells were isolated, plated on collagen-coated plates and grown in the proliferating medium (ESM Methods). Magnetic cell separation with CD56 antibody was used to select primary myoblasts, which were differentiated into myotubes. The cells were starved of serum for 2 h in low-glucose DMEM before experiments. Myotubes were exposed to 100 μmol/l RSV, 1 mmol/l 5-aminoimidazole-4-carboxamide-1-β-d-ribonucleoside (AICAR), 20 μmol/l Compound C (a potent reversible inhibitor of AMPK ) or 0.2 mmol/l palmitate, or their combination, for 4 h. In dose–response experiments 0.1–200 μmol/l RSV was used. For the time course experiments, the cells were incubated with 100 μmol/l RSV for up to 24 h.
Myogenin staining was performed on cells grown on glass coverslips to determine the differentiation of myoblasts into myotubes (ESM Methods). The cells were permeabilised with −20°C methanol, blocked in 5% BSA–0.01% Triton-X 100, and incubated with anti-myogenin. After incubation with secondary antibody the coverslips were mounted with Mowiol. The images were acquired using an AXIOVERT 200 M microscope (Carl Zeiss, Tuusula, Finland).
Glucose uptake and glycogen synthesis
Serum-starved myotubes were exposed for 4 h to 100 μmol/l RSV, 100 nmol/l insulin, 1 mmol/l AICAR and 20 μmol/l Compound C, with only a trace amount of 9,10-[3H]palmitic acid in the medium (5 μCi/ml). In separate experiments, we also performed fatty-acid oxidation assay in the presence of 0.2 mmol/l cold palmitate. Palmitate oxidation was analysed by measuring 3H-labelled water, as described .
Protein detection was performed by western blotting using enhanced chemiluminescence. Proteins were quantified by densitometry using the ImageJ Software (NIH, USA, http://rsbweb.nih.gov/ij/).
Human primary myotubes were exposed to 1 or 100 μmol/l RSV for 4 h, lysed in ice-cold immunoprecipitation lysing buffer, and 250 μg total protein was incubated with anti-PGC-1α antibodies overnight at 4°C (ESM Methods). Protein A-agarose was added, and the agarose-immunocomplex was pelleted and dissolved in 1× Laemmli Buffer. PGC-1α acetylation was analysed by western blotting with anti-acetyl-lysine antibodies.
AMPK kinase activity assay
Activity of both AMPK isoforms (α1/β2/γ1 and α2/β2/γ1) was measured according to the manufacturer’s protocol (SignalChem Pharmaceuticals Inc, Richmond, BC), as described in ESM Methods. Briefly, 300 ng of AMPK was incubated with 1 or 100 μmol/l RSV, 1 mmol/l AICAR, 1 mmol/l 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranosyl 5′monophosphate (ZMP) or 20 μmol/l Compound C in kinase assay buffer in the presence of synthetic peptide substrate for AMPK (SAMS) and AMP for 2 h at 30°C. Then 5 μl of 250 μmol/l 33P-labelled ATP (Perkin Elmer, Waltham, MA, USA) Assay Cocktail (SignalChem Pharmaceuticals, Richmond, BC, Canada) was added and the reaction mixture was incubated for 15 min. The reaction was terminated by spotting 20 μl into the P81 paper strip, and radioactivity was counted in a scintillation counter.
Cell viability assay
Human primary or L6 myotubes were treated with different doses of RSV (0.1–200 μmol/l) for 4 h to assess the toxicity of RSV using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) test (ESM Methods). MTT compound, which is reduced from yellow tetrazole to purple formazone in intact and living cells, was added and the absorbance was measured at 560 nm.
All results are presented as means ± SE. One-way ANOVA with repeated measurements was used to analyse the data, unless noted otherwise (Prism 4; GraphPad Software, http://www.graphpad.com). A p value of <0.05 was considered significant.
Differentiation of the human primary muscle cells
The levels of the muscle-specific transcription factor myogenin was analysed using immunocytochemistry (ESM Fig. 1). Myogenin levels were transiently increased with a maximum at 3 days and return to basal at 7 days (ESM Fig. 1 and data not shown). The formation of myotubes was significantly increased 3 days after the induction of differentiation, with further differentiation by 7 days. To confirm formation of myotubes we also assessed the abundance of desmin, a structural protein specific for muscle cells. Desmin levels progressively increased during the differentiation period, with the maximum reached at day 7 (data not shown). Thus, we chose 7 days of differentiation for further experiments.
Palmitate oxidation was first determined using only a trace amount of radiolabelled palmitate in the media (without any cold palmitate, Fig. 2b). Insulin stimulated palmitate oxidation, most likely due to increased palmitate uptake into cells . However, in the presence of RSV, palmitate oxidation was reduced by 40% (p < 0.05). AICAR increased palmitate oxidation whereas in the presence of Compound C palmitate oxidation was inhibited. Next, palmitate oxidation was analysed at physiological palmitate concentration (0.2 mmol/l). As expected, in this experimental set-up, insulin tended to decrease palmitate oxidation (Fig. 2c). Exposure of human muscle cells to RSV led to decreased palmitate oxidation rate.
Effect of RSV on AKT phosphorylation
Effect of RSV on AMPK signalling pathway
RSV increases PGC-1α acetylation in human myotubes
Activation of SIRT1 by RSV requires AMPK activation and leads to deacetylation (and activation) of transcriptional coactivator PGC-1α in nonhuman cell and animal models [13, 14]. To study SIRT1 activation in primary human myotubes, we exposed cells to 1 or 100 μmol/l RSV for 4 h and determined PGC-1α acetylation. Acute exposure to 1 μmol/l RSV significantly increased acetylation of PGC-1α in human primary myotubes, suggesting inhibition of SIRT1 activity and increased activation of acetyltransferases by RSV (Fig. 4e). The change in PGC-1α acetylation in response to 100 μmol/l RSV was not statistically significant.
In-vitro effect of RSV on AMPK activity
RSV increases ER stress in human and L6 myotubes
Activation of UPR during ER stress also results in induction of CCAAT/enhancer binding protein homologous protein (CHOP) and chaperone protein binding immunoglobulin protein (BiP) . Treatment of human myotubes with RSV increased CHOP levels in a dose-dependent manner up to 100 μmol/l (Fig. 6c). BiP levels were unaffected by RSV in human muscle cells (Fig. 6d). In L6 myotubes, eIF2α phosphorylation was increased in response to 100 or 200 μmol/l RSV but was not affected by lower RSV concentrations (ESM Fig. 5a). The production of CHOP was increased by RSV at a concentration 10 μmol/l or higher (ESM Fig. 5b), whereas BiP levels were increased at all RSV concentrations (from 0.1 μmol/l upwards) in L6 myotubes (ESM Fig. 5c).
Time course effect of RSV on protein phosphorylation
To determine whether the inhibitory action of RSV was time-dependent, we performed a time course experiment where the level of phosphorylation of AKT, AMPK, ACC and eIF2α was analysed in human skeletal muscle cells (ESM Fig. 6). Treatment with 100 μmol/l RSV decreased insulin-mediated phosphorylation of AKT-Ser473 and this inhibition was maintained for 24 h (ESM Fig. 6a). There was a nonsignificant trend for decreased AMPK phosphorylation after 2–12 h incubation with RSV, with a return to basal after 24 h (ESM Fig. 6b). Exposure to RSV reduced phosphorylation of ACCβ and this effect was maintained for 12 h (p < 0.05, ESM Fig. 6c). ACCβ phosphorylation was restored to basal levels after 24 h exposure to RSV. eIF2α-Ser52 phosphorylation was increased by RSV at all time points up to 24 h (p < 0.05, ESM Fig. 6d).
The natural polyphenolic compound RSV has recently attracted considerable scientific interest due to its glucose-lowering properties. In rodent models, RSV improves the action of insulin and improves whole-body glucose homeostasis [13, 14, 28–30]. RSV has also been shown to be involved in the reduction of fat accumulation and body weight [13, 29, 31]. Since type 2 diabetes is characterised by defects in glucose metabolism and is often associated with obesity, these findings have raised hope that RSV or compounds with similar mode of action could be used to improve metabolic control and alleviate overweight in insulin-resistant patients. Therefore, it is important to understand the mechanisms whereby RSV influences metabolism. Since skeletal muscle is the main site of glucose use under insulin-stimulated conditions [32, 33], we have studied herein the metabolic effects of RSV on glucose and lipid metabolism using cultured primary human skeletal muscle cells.
First, we studied the effect of RSV on glucose metabolism in primary human myotubes. In the basal state, glucose uptake was unaffected by the presence of RSV. However, glucose incorporation into glycogen in the basal state, as well as insulin-stimulated glucose uptake and glycogen synthesis, were significantly reduced by RSV. These data were surprising, since RSV has previously been shown to stimulate glucose uptake in L6 muscle cells through the activation of insulin and AMPK signalling cascades [34, 35]. To determine whether the effects of RSV on glucose uptake were concentration or species dependent, we performed a dose–response experiment using primary human myotubes and a rat-derived cell line, L6 cells. In human myotubes, we observed increased basal glucose uptake with lower RSV concentrations (1 and 10 μmol/l) and an inhibition of basal and insulin-stimulated glucose uptake by higher RSV concentrations (100 and 200 μmol/l). In L6 myotubes, RSV 0.1–100 μmol/l did not affect basal glucose uptake, whereas basal glucose uptake was inhibited by 200 μmol/l RSV. Similar to human myotubes, insulin-stimulated glucose uptake was inhibited by 100 and 200 μmol/l RSV. The reason for different findings is not readily apparent since the concentrations of RSV and duration of exposure have been similar in previous studies [34, 35]. The inhibitory effect of higher RSV concentration on glucose uptake was also similar in human and L6 myotubes in our study, excluding an effect of possible species differences. It is interesting that lower concentrations of RSV enhanced basal glucose uptake in human myotubes, while higher concentrations were inhibitory. These data would be compatible with the concept of hormesis: lower concentrations of RSV seem to exert positive, whereas higher concentrations of RSV seem to exert negative, biological effects, similar to what has been suggested for oxidative stress .
Our original working hypothesis was that RSV could reverse palmitate-induced insulin resistance in human muscle cells, as it does in C2C12 muscle cells . However, we observed no such effect. The defect in glucose incorporation into glycogen was more pronounced in the presence of RSV. Thus, exposure to RSV impairs insulin action in human primary myotubes and does not protect cells from lipid-induced insulin resistance. Consistent with the negative effects on glucose metabolism, RSV attenuated insulin-stimulated phosphorylation of AKT, an effect sustained for 24 h. RSV-induced inhibition of insulin action on glucose uptake or insulin signalling has previously been reported also in other studies [37–39], and RSV has been shown to be a direct inhibitor of class IA PI3-kinase . More specifically , 100 μmol/l RSV for 30 min fully inhibited insulin-stimulated AKT phosphorylation at Ser473 and Thr308 as well as the activation of PI3-kinase in a dose-dependent fashion (5–100 μmol/l) in primary human myotubes. Insulin-stimulated AKT Ser473 phosphorylation was inhibited by 10–100 μmol/l RSV also in rat L6 and human rhabdomyosarcoma CCL muscle-derived cells. Further analysis revealed that RSV targeted the ATP-binding site of PI3K in a competitive and reversible manner. Insulin-stimulated glucose uptake was reduced 82.7% also in 3T3-L1 adipocytes by 100 μmol/l RSV . RSV decreased basal glucose uptake in two myelocytic cell lines, U937 and HL-60 cells, with a dose-dependent inhibition from 20 to 120 μmol/l and 50% inhibition at approximately 73–75 μmol/l . Zhang reported that RSV, at similar concentrations to ours (1–200 μmol/l), inhibited insulin-stimulated AKT signalling in H4IIE cells (a rat hepatoma cell line), HepG2 cells (a human hepatoma cell line, RSV 100 μmol/l) and primary rat hepatocytes (RSV 100 μmol/l) . Taken together, RSV inhibits glucose metabolism and AKT signalling in several different cell models.
RSV increases mitochondrial biogenesis and physical endurance and reduces weight, fat accumulation and muscle DAG content in rodent models [13, 14, 28]. Since these data suggest that RSV has beneficial effects on lipid metabolism, we investigated whether RSV affects fatty-acid oxidation in human skeletal muscle cells. As expected, exposure of muscle cells to AICAR increased palmitate oxidation. However, in the presence of RSV, palmitate oxidation was severely compromised. The marked inhibition of basal palmitate oxidation by the AMPK inhibitor Compound C points to a pivotal role of AMPK activity in regulation of fatty-acid oxidation, as suggested . Taken together, our data on both glucose and lipid metabolism suggest that RSV acts as a metabolic inhibitor in human skeletal muscle cells and also raise the possibility that RSV inhibits AMPK activity.
Activation of AMPK by 10–100 μmol/l RSV has been reported in several studies [13, 28, 31, 34, 37]. We analysed the effect of RSV on the activation of the AMPK pathway in human primary muscle cells. Acute exposure to 100 or 200 μmol/l RSV inhibited activation of the AMPK pathway in human myotubes, as demonstrated by decreased phosphorylation of AMPK and ACC. The inhibitory effect of RSV on the AMPK signalling pathway was maintained for 12 h with a return to basal by 24 h. The AMPK pathway is known to be the main regulator of fatty-acid oxidation  and, thus, the inhibition of AMPK signalling is in line with our metabolic data showing reduced palmitate oxidation by RSV. Interestingly, we found that lower RSV concentrations (0.1 and 10 μmol/l) did not affect AMPK or ACCβ phosphorylation in human myotubes. In L6 myotubes, all RSV concentrations used (0.1–200 μmol/l) activated AMPK (as demonstrated by increased ACC phosphorylation), suggesting some species differences in response to RSV.
NAD+-dependent deacetylase SIRT1 deacetylates and thereby activates transcriptional coactivator PGC-1α; SIRT1 activation by RSV requires intact AMPK activity [13, 14]. To ascertain whether RSV activates SIRT1 in primary human myotubes, PGC-1α acetylation was determined. Acute exposure to 1 μmol/l RSV significantly increased acetylation of PGC-1α in human primary myotubes, which is the total opposite to what we expected. These data suggest that RSV acutely inhibits SIRT1 activity and may increase the activation of acetyltransferases. Given that SIRT1 activation by RSV is downstream of AMPK [13, 14], the observed increase in PGC-1α acetylation and inhibition of the AMPK-ACC signalling pathway suggest that RSV directly inhibits AMPK activity in human myotubes. To confirm this hypothesis, we examined the effect of RSV on activation of both α1/β2/γ1 and α2/β2/γ1 isoform complexes of AMPK in in-vitro kinase assays. RSV blocked the activity of both isoform complexes of AMPK in our study. Taken together, our data suggest that RSV is an inhibitor of AMPK in human skeletal muscle cells.
In contrast to our findings, 30-day treatment with RSV resulted in increased phosphorylation of AMPK in human skeletal muscle . Thus, it is possible that acute and chronic effects of RSV may be different. Alternatively, the increase in AMPK phosphorylation in human muscle following 30-day treatment may be a secondary effect. In accordance, Park et al recently reported that RSV inhibits cAMP phosphodiesterases 1, 3 and 5; resulting elevation of cAMP activates cAMP-regulated guanine nucleotide exchange factor Epac1 and leads secondarily to AMPK activation via increased intracellular Ca2+ concentration and activation of calcium/calmodulin dependent protein kinase β (CamKKβ) via phospholipase C and the ryanodine receptor Ca2+-release channel . Interestingly, despite an increase in AMPK phosphorylation in skeletal muscle, 30-day peroral RSV therapy led to a decrease in sleeping and resting metabolic rate . This might be compatible with RSV-induced inhibition of glucose metabolism and insulin signalling observed in our and other studies [37–39], as well as observed RSV-induced inhibition of fatty-acid metabolism.
ER stress has emerged as an important contributor to the pathogenesis of insulin resistance. Here, we tested the effect of RSV on ER stress using phosphorylation of eIF2α or CHOP levels as readouts. eIF2α is a downstream target of the PKR-like endoplasmic reticulum kinase (PERK) signalling arm of the UPR and its phosphorylation leads to global inhibition of translation, thus protecting cells from accumulation of misfolded proteins that aggravate ER stress . Exposure of muscle cells to palmitate increased eIF2α phosphorylation, which is compatible with previous data and verifies the notion that excess nutrients create ER stress. Interestingly, exposure to RSV also increased eIF2α phosphorylation and CHOP levels in a dose-dependent fashion suggesting that RSV induces ER stress. The effect of RSV on eIF2α phosphorylation and CHOP levels was also observed in L6 myotubes, whereas BiP was induced by RSV in L6 cells but not in human myotubes. Exposure of human muscle cells to AICAR resulted in a decrease in eIF2α phosphorylation, suggesting that AMPK activation alleviates ER stress. It has been reported that AMPK activation improves ER-stress-induced insulin resistance . This may be an essential part of the mechanisms whereby AMPK activation mediates its beneficial effects on metabolism. The effects of AICAR and other AMPK activators on ER stress need to be studied in more detail in the future, as the findings may reveal prospective new targets for drug development.
In conclusion, acute exposure to RSV has a negative impact on glucose and lipid metabolism in human primary muscle cells. RSV inhibits insulin-stimulated AKT Ser473 phosphorylation, an effect maintained for 24 h. Furthermore, RSV increases ER stress and inhibits the AMPK signalling pathway in human skeletal muscle, as demonstrated by diminished phosphorylation of AMPK and ACC as well as direct inhibition of AMPK activity. AICAR reduces ER stress in muscle cells and thus targeting ER stress via AMPK pathway may reveal novel targets to treat metabolic diseases.
This study was supported by grants from the Finnish Academy of Science (grant no. 127093), Finnish Cultural Foundation, Finnish Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, Finnish Medical Foundation, Liv och Hälsa Foundation, Novo Nordisk Foundation, Paulo Foundation, Sigrid Juselius Foundation, the governmental subsidy for research of Helsinki University Central Hospital (EVO-funding), and the Research Council of University of Helsinki. P. Skrobuk has received grant support from Finska Läkaresällskapet, University of Helsinki and Paulo Foundation.
PS, SK, MS, AZ and HK designed the study, researched and interpreted the data; PS and HK wrote the manuscript while SK, MS and AZ participated in its revision; all authors have approved the submitted manuscript.
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.